Marita Fuhrer
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.
Journal: EBioMedicine
Published: November 15, 2024
A ONECUT1 regulatory, non-coding region in pancreatic development and diabetes.
Journal: Cell reports
Published: June 17, 2024
Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti.
Journal: Journal of clinical immunology
Published: February 01, 2024
Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
Journal: The Journal of allergy and clinical immunology
Published: September 21, 2023
Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Journal: The Journal of allergy and clinical immunology
Published: March 23, 2023
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS.
Journal: The Journal of experimental medicine
Published: November 20, 2019
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 17, 2019
Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 29, 2018
Activated PI3Kδ syndrome type 2: Two patients, a novel mutation, and review of the literature.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: April 24, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026